- Advantage for Sponsors to utilize digital subject reporting outcomes (eDiary) in clinical trials
- EFSA’s work on the update or rather reduction of ULs
- Impressions of Probiota 2023: Call for harmonisation and need for clinical trials
- Medical Device Regulation Extension of transition period approved, but what are the implications?
- First Novel food approval for insects in supplements